Neuromuscular Transmission
Neuromuscular Transmission - Related Videos
10:40
Measuring Neuromuscular Junction Functionality
0 Views •
Cited by 7 •
2017
A functional assessment of the neuromuscular junction (NMJ) can provide essential information on the communication between muscle and nerve. Here we describe a protocol to comprehensively evaluate both the NMJ and muscle functionality using two different muscle-nerve preparations, i.e. soleus-sciatic and diaphragm-phrenic.
02:08
Assessing Muscle Contraction with Neuromuscular Blocker Treatment
0 Views •
2025
This video demonstrates assessing the muscle using cultured motor neurons, Schwann cells, and myotubes, followed by treatment with a neuromuscular blocker to inhibit contraction. Color-coded time-motion graphics show a color-coded time-motion graphic. Red indicates the fastest movement, and blue indicates the slowest.
18:01
Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
0 Views •
Cited by 20 •
2008
This video demonstrates how to employ two neural stimulants, aldicarb and pentylenetetrazole (PTZ), in complementary ways to study synaptic function in the nematode, C. elegans. This complementary approach may also be used to shed light on evolutionarily conserved mechanisms for modulating neuronal synchrony and has implications for epilepsy and seizures.
05:54
Optimizing Sample Preparation Process for Transmission Electron Microscopy of Neuromuscular Junctions in Drosophila Larvae
0 Views •
2023
This report provides a new sample preparation procedure for visualizing neuromuscular junctions in Drosophila Larvae. This method is more effective in preventing the curling of the samples compared to the traditional method and is particularly useful for Drosophila neuromuscular junction ultrastructural analysis.
10:45
Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions
0 Views •
Cited by 9 •
2018
The protocol described in this paper uses the mouse levator auris longus (LAL) muscle to record spontaneous and nerve-evoked postsynaptic potentials (current-clamp) and currents (voltage-clamp) at the neuromuscular junction. Use of this technique can provide key insights into mechanisms of synaptic transmission under normal and disease conditions.
FAQs
Voltage-gated calcium channels connect the arriving motor-nerve action potential to acetylcholine release. When the action potential reaches the nerve terminal, these channels open and initiate the release of acetylcholine into the neuromuscular junction. Their position in the sequence makes calcium-channel activity a key control point for studying how neuronal excitation produces a muscle response.
After its release, acetylcholine activates nicotinic receptors on the skeletal muscle membrane. This receptor activation produces an end-plate potential, which represents the electrical response of the muscle membrane to motor-neuron signaling. Pharmacological studies can therefore examine the receptor step separately from earlier events, such as action-potential arrival or acetylcholine release.
Pharmacological agents can enhance, inhibit, or prolong signaling at the neuromuscular junction. These effects allow investigators to distinguish whether a drug increases communication, suppresses it, or extends its functional influence. Comparing these patterns helps relate changes in junctional signaling to the resulting effects on skeletal muscle function without treating transmission as a single, unmodifiable event.
The process links motor-neuron activity with skeletal muscle contraction, so changing it can directly influence movement and muscle function. This makes the neuromuscular junction useful for examining drug effects on neuronal communication and muscle activation. It also provides a pharmacological framework for investigating disorders and interventions that alter the normal communication pathway.
Myasthenia gravis is identified in the overview as a condition for which pharmacological manipulation of neuromuscular signaling is relevant. Studying agents that enhance, inhibit, or prolong transmission can help researchers and clinicians examine how altered junctional communication affects muscle function. The process therefore connects cellular signaling mechanisms with investigation and management of this disorder.
Neuromuscular blockers are used to inhibit signaling between motor neurons and skeletal muscle, producing controlled paralysis during surgery. Their application demonstrates how pharmacology can deliberately suppress the pathway that normally supports contraction. In this context, the neuromuscular junction becomes a controllable target for anesthesia-related procedures rather than only a system used to study normal movement.